BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter.
On a per-share basis, the Boston-based company said it had a loss of 20 cents.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The company posted revenue of $1.4 million in the period, beating Street forecasts. Five analysts surveyed by Zacks expected $958,000.
For the year, the company reported a loss of $37.5 million, or 19 cents per share. Revenue was reported as $2.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XFOR at https://www.zacks.com/ap/XFOR
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
